Targeting EphA2 in Bladder Cancer Using a Novel Antibody-Directed Nanotherapeutic
Walid S. Kamoun(Harvard University), Daryl C. Drummond(AVEO Oncology (United States))
Cited by 18
Related Papers
Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles
|Nature Nanotechnology|2023|149
Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastine
|Cancer Chemotherapy and Pharmacology|2009|73